Comments on: An 11th-Hour Battle Over Biogenerics In Congress http://www.pharmalot.com/2010/01/an-11th-hour-battle-over-biogenerics-in-congress/ News, Comment and Conversation Fri, 10 Feb 2012 20:55:43 +0000 http://wordpress.org/?v=2.6.2 By: M. Black http://www.pharmalot.com/2010/01/an-11th-hour-battle-over-biogenerics-in-congress/#comment-458365 M. Black Fri, 15 Jan 2010 21:14:45 +0000 http://www.pharmalot.com/?p=20936#comment-458365 I think the larger, more looming issue is the fact that many if not most (including pharmacists) truly believe that a generic is equally as potent as a brand name drug. If patients can't tell the difference, they likely either do not need the prescribed medication, or may have been misdiagnosed. Depending on the illness and generic drug used to treat it, this can be fatal. That is not acceptable. I think the larger, more looming issue is the fact that many if not most (including pharmacists) truly believe that a generic is equally as potent as a brand name drug. If patients can’t tell the difference, they likely either do not need the prescribed medication, or may have been misdiagnosed. Depending on the illness and generic drug used to treat it, this can be fatal.

That is not acceptable.

]]> By: Outside the Box http://www.pharmalot.com/2010/01/an-11th-hour-battle-over-biogenerics-in-congress/#comment-458291 Outside the Box Fri, 15 Jan 2010 14:46:58 +0000 http://www.pharmalot.com/?p=20936#comment-458291 Surely someone at PhRMA can calculate the likely value to the industry of each additional year of bio exclusivity and as a result come up with a proposal to reduce the time to close the donut hole in return for longer exclusivity? Given that this whole process has been one big horse trade why not make it clear that this is what is being done? Surely someone at PhRMA can calculate the likely value to the industry of each additional year of bio exclusivity and as a result come up with a proposal to reduce the time to close the donut hole in return for longer exclusivity? Given that this whole process has been one big horse trade why not make it clear that this is what is being done?

]]> By: Fred Nelson http://www.pharmalot.com/2010/01/an-11th-hour-battle-over-biogenerics-in-congress/#comment-458281 Fred Nelson Fri, 15 Jan 2010 13:43:24 +0000 http://www.pharmalot.com/?p=20936#comment-458281 Moving the exclusivity period down from 12 years could be costly to the BioTech Industry. They had thought they dodged a bullet. Interestingly Obama believes 7 years is to right number. Also, with regard to the additional $10 billion from Pharma... This apparently will go to fill the Donut Hole which may signal a shorter time frame to close the Donut Hole. Last week Senator Whitehouse from RI said that there were discussion to close it sooner than 2019 which is in the House legislation. Could these be the funds earmarked to close it sooner? Moving the exclusivity period down from 12 years could be costly to the BioTech Industry. They had thought they dodged a bullet. Interestingly Obama believes 7 years is to right number.

Also, with regard to the additional $10 billion from Pharma… This apparently will go to fill the Donut Hole which may signal a shorter time frame to close the Donut Hole. Last week Senator Whitehouse from RI said that there were discussion to close it sooner than 2019 which is in the House legislation. Could these be the funds earmarked to close it sooner?

]]>